Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial

AIMS: The REGENERATE-DCM trial is the first phase II randomized, placebo-controlled trial aiming to assess if granulocyte colony-stimulating factor (G-CSF) administration with or without adjunctive intracoronary (IC) delivery of autologous bone marrow-derived cells (BMCs) improves global left ventri...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamshere, Stephen, Arnous, Samer, Choudhury, Tawfiq, Choudry, Fizzah, Mozid, Abdul, Yeo, Chia, Barrett, Catherine, Saunders, Natalie, Gulati, Ankur, Knight, Charles, Locca, Didier, Davies, Ceri, Cowie, Martin R., Prasad, Sanjay, Parmar, Mahesh, Agrawal, Samir, Jones, Daniel, Martin, John, McKenna, William, Mathur, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654774/
https://www.ncbi.nlm.nih.gov/pubmed/26333366
http://dx.doi.org/10.1093/eurheartj/ehv390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654774/
https://www.ncbi.nlm.nih.gov/pubmed/26333366
http://dx.doi.org/10.1093/eurheartj/ehv390

Ejemplares similares